The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-elected

Sharon Brunecz Biography and Net Worth

Insider of Amedisys

Sharon Brunecz serves as Chief Human Resource Officer of the Company. With more than 20 years of experience, Ms. Brunecz is an expert in leading human capital strategies that drive business outcomes including talent management, total rewards, organizational and leadership development, employee engagement, talent acquisition, metrics and analytics, and merger and acquisitions. Prior to joining Amedisys, Ms. Brunecz served as Chief Human Resources Officer from September 2015 to June 2018 for US Acute Care Solutions (USACS), the nation’s leading physician-owned provider of integrated acute care services offering emergency, hospitalist and observation medicine to hospital partners. In this role, she had overall accountability for Human Resources, Corporate Communications and Marketing functions. Prior to USACS, Ms. Brunecz held several HR leadership positions with PNC Financial Services Group, a diversified financial services company, from 1998 to 2015.

What is Sharon Brunecz's net worth?: The estimated net worth of Sharon Brunecz is at least $2.00 million as of September 2nd, 2020. Ms. Brunecz owns 22,100 shares of Amedisys stock worth more than $2,003,144 as of November 24th. This net worth approximation does not reflect any other investments that Ms. Brunecz may own. Learn More about Sharon Brunecz's net worth.
How do I contact Sharon Brunecz?: The corporate mailing address for Ms. Brunecz and other Amedisys executives is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. Amedisys can also be reached via phone at (225) 292-2031 and via email at [email protected]. Learn More on Sharon Brunecz's contact information.
Has Sharon Brunecz been buying or selling shares of Amedisys?: Sharon Brunecz has not been actively trading shares of Amedisys within the last three months. Most recently, Sharon Brunecz sold 4,367 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $245.37, for a transaction totalling $1,071,530.79. Following the completion of the sale, the insider now directly owns 22,100 shares of the company's stock, valued at $5,422,677. Learn More on Sharon Brunecz's trading history.
Who are Amedisys' active insiders?: Amedisys' insider roster includes Denise Bohnert (Insider), Sharon Brunecz (Insider), Christopher Gerard (COO), Scott Ginn (CFO), David Kemmerly (Insider), Richard Lechleiter (Director), Michael North (Insider), and Bruce Perkins (Director). Learn More on Amedisys' active insiders.

Sharon Brunecz Insider Trading History at Amedisys

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/2/2020	Sell	4,367	$245.37	$1,071,530.79	22,100
6/19/2020	Sell	2,185	$196.00	$428,260.00	23,327
8/9/2019	Sell	1,050	$136.28	$143,094.00	11,480

Sharon Brunecz Buying and Selling Activity at Amedisys

Amedisys Company Overview

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Today's Range

Now: $90.64

$90.00

$90.71

50 Day Range

MA: $95.34

$89.45

$97.71

2 Week Range

Now: $90.64

$88.81

$98.95

Volume

390,872 shs

Average Volume

682,878 shs

Market Capitalization

$2.97 billion

P/E Ratio

35.97

Dividend Yield

N/A

Beta

0.78

From StockEarnings | Ad